Capital Impact Advisors’s Guardant Health GH Stock Holding History

Capital Impact Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,619	Closed	-$343K	–	75
2024 Q1	$343K	Sell	16,619 -18,600	-53%	-$399K	0.45%	82
2023 Q4	$953K	Buy	35,219 +24,797	+238%	+$650K	1.25%	29
2023 Q3	$309K	Hold	10,422	–	–	0.52%	79
2023 Q2	$373K	Buy	10,422 +1,059	+11%	+$30.4K	0.41%	116
2023 Q1	$219K	Buy	+9,363	New	+$267K	0.27%	146
2021 Q4	–	Sell	-16,975	Closed	-$2.12M	–	116
2021 Q3	$2.12M	Sell	16,975 -4,227	-20%	-$502K	0.84%	54
2021 Q2	$2.63M	Buy	21,202 +12,797	+152%	+$1.72M	0.85%	49
2021 Q1	$1.28M	Sell	8,405 -14,538	-63%	-$2.2M	0.45%	79
2020 Q4	$2.96M	Hold	22,943	–	–	0.73%	60
2020 Q3	$2.56M	Sell	22,943 -10,000	-30%	-$915K	0.76%	60
2020 Q2	$2.67M	Hold	32,943	–	–	0.89%	45
2020 Q1	$2.29M	Buy	32,943 +1,272	+4%	+$97.6K	0.96%	35
2019 Q4	$2.48M	Buy	31,671 +11,682	+58%	+$842K	0.87%	29
2019 Q3	$1.25M	Hold	19,989	–	–	0.48%	107
2019 Q2	$1.68M	Buy	+19,989	New	+$1.53M	0.62%	91

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Capital Impact Advisors's GH Position: Q2 2024 in Review

Capital Impact Advisors sold out of Guardant Health (GH) in Q2 2024, closing a stake of 16,619 shares — an estimated $343K sold.

Capital Impact Advisors first reported a position in GH in Q2 2019 and held it in 15 quarters. The position peaked at $2.96M in Q4 2020. 282 funds tracked by Wall St. Rank hold GH as of Q2 2024.

Capital Impact Advisors reported no remaining Guardant Health position as of Q2 2024 after selling out during the quarter.
Capital Impact Advisors sold 16,619 Guardant Health shares in Q2 2024, an estimated $343K.
Capital Impact Advisors first reported a position in Guardant Health in Q2 2019 and held it in 15 quarters.
Capital Impact Advisors's Guardant Health position peaked at $2.96M in Q4 2020.
282 funds tracked by Wall St. Rank held Guardant Health as of Q2 2024.

Based on Capital Impact Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.